Analyst Downgrades – NASDAQ:ARMO – ARMO BioSciences (NASDAQ:ARMO) Stock Gets Downgraded By Jefferies Financial Group from Buy ➝ Hold to

Analyst Ratings For NASDAQ:ARMO – ARMO BioSciences (NASDAQ:ARMO)

Story continues below

Today, NASDAQ:ARMO – ARMO BioSciences (NASDAQ:ARMO) stock was downgraded by Jefferies Financial Group from Buy ➝ Hold to with a price target of $61.00 ➝ $50.00.

Some recent analyst ratings include

  • 6/13/2018-Jefferies Financial Group was Downgraded by analysts at Jefferies Financial Group from a “Buy ➝ Hold” rating to a “” rating. They now have a $61.00 ➝ $50.00 price target on the stock.
  • 5/10/2018-Robert W. Baird was Downgraded by analysts at Robert W. Baird from a “Outperform ➝ Neutral” rating to a “” rating. They now have a $67.00 price target on the stock.
  • 5/10/2018-BMO Capital Markets was Downgraded by analysts at BMO Capital Markets from a “Outperform ➝ Market Perform” rating to a “” rating. They now have a $75.00 price target on the stock.
  • 5/10/2018-Leerink Swann was Downgraded by analysts at Leerink Swann from a “Outperform ➝ Market Perform” rating to a “” rating. They now have a $50.00 price target on the stock.


    Recent Trading Activity for NASDAQ:ARMO – ARMO BioSciences (NASDAQ:ARMO)
    Shares of NASDAQ:ARMO – ARMO BioSciences closed the previous trading session at 49.98 up +0.01 0.03% with 49.9900016784668 shares trading hands.

    An ad to help with our costs